Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: a single-blind randomized controlled trial

Overview of attention for article published in Neuropsychiatric Disease and Treatment, June 2018

Altmetric Badge